1.
Ahmad A, Attique Abou Bakr, Yasir Mahmud, Raja Taha Yaseen Khan, Ghulam Abbas. Comparative Validity of the ALBI Grade and CTP Score in Predicting Overall Survival in Patients Receiving TACE Plus Sorafenib Therapy for Hepatocellular Carcinoma. JHRR [Internet]. 2024 Jun. 7 [cited 2024 Nov. 21];4(2):1179-84. Available from: https://jhrlmc.com/index.php/home/article/view/913